161 related articles for article (PubMed ID: 18579125)
1. Flavonoids as inhibitors of human carbonyl reductase 1.
Carlquist M; Frejd T; Gorwa-Grauslund MF
Chem Biol Interact; 2008 Jul; 174(2):98-108. PubMed ID: 18579125
[TBL] [Abstract][Full Text] [Related]
2. Structure-activity relationship of flavonoids as potent inhibitors of carbonyl reductase 1 (CBR1).
Arai Y; Endo S; Miyagi N; Abe N; Miura T; Nishinaka T; Terada T; Oyama M; Goda H; El-Kabbani O; Hara A; Matsunaga T; Ikari A
Fitoterapia; 2015 Mar; 101():51-6. PubMed ID: 25549925
[TBL] [Abstract][Full Text] [Related]
3. Characterization of the Canine Anthracycline-Metabolizing Enzyme Carbonyl Reductase 1 (cbr1) and the Functional Isoform cbr1 V218.
Ferguson DC; Cheng Q; Blanco JG
Drug Metab Dispos; 2015 Jul; 43(7):922-7. PubMed ID: 25918240
[TBL] [Abstract][Full Text] [Related]
4. Two nonsynonymous single nucleotide polymorphisms of human carbonyl reductase 1 demonstrate reduced in vitro metabolism of daunorubicin and doxorubicin.
Bains OS; Karkling MJ; Grigliatti TA; Reid RE; Riggs KW
Drug Metab Dispos; 2009 May; 37(5):1107-14. PubMed ID: 19204081
[TBL] [Abstract][Full Text] [Related]
5. Carbonyl reductase 1 is a predominant doxorubicin reductase in the human liver.
Kassner N; Huse K; Martin HJ; Gödtel-Armbrust U; Metzger A; Meineke I; Brockmöller J; Klein K; Zanger UM; Maser E; Wojnowski L
Drug Metab Dispos; 2008 Oct; 36(10):2113-20. PubMed ID: 18635746
[TBL] [Abstract][Full Text] [Related]
6. Potent inhibition of human carbonyl reductase 1 (CBR1) by the prenylated chalconoid xanthohumol and its related prenylflavonoids isoxanthohumol and 8-prenylnaringenin.
Seliger JM; Martin HJ; Maser E; Hintzpeter J
Chem Biol Interact; 2019 May; 305():156-162. PubMed ID: 30849340
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory effect of quercetin on matrix metalloproteinase 9 activity molecular mechanism and structure-activity relationship of the flavonoid-enzyme interaction.
Saragusti AC; Ortega MG; Cabrera JL; Estrin DA; Marti MA; Chiabrando GA
Eur J Pharmacol; 2010 Oct; 644(1-3):138-45. PubMed ID: 20619256
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of polymorphic human carbonyl reductase 1 (CBR1) by the cardioprotectant flavonoid 7-monohydroxyethyl rutoside (monoHER).
Gonzalez-Covarrubias V; Kalabus JL; Blanco JG
Pharm Res; 2008 Jul; 25(7):1730-4. PubMed ID: 18449627
[TBL] [Abstract][Full Text] [Related]
9. A functional genetic polymorphism on human carbonyl reductase 1 (CBR1 V88I) impacts on catalytic activity and NADPH binding affinity.
Gonzalez-Covarrubias V; Ghosh D; Lakhman SS; Pendyala L; Blanco JG
Drug Metab Dispos; 2007 Jun; 35(6):973-80. PubMed ID: 17344335
[TBL] [Abstract][Full Text] [Related]
10. Spectrophotometric analysis of flavonoid-DNA binding interactions at physiological conditions.
Janjua NK; Siddiqa A; Yaqub A; Sabahat S; Qureshi R; ul Haque S
Spectrochim Acta A Mol Biomol Spectrosc; 2009 Dec; 74(5):1135-7. PubMed ID: 19836298
[TBL] [Abstract][Full Text] [Related]
11. Comparative evaluation of quercetin, isoquercetin and rutin as inhibitors of alpha-glucosidase.
Li YQ; Zhou FC; Gao F; Bian JS; Shan F
J Agric Food Chem; 2009 Dec; 57(24):11463-8. PubMed ID: 19938837
[TBL] [Abstract][Full Text] [Related]
12. Studies on reduction of S-nitrosoglutathione by human carbonyl reductases 1 and 3.
Staab CA; Hartmanová T; El-Hawari Y; Ebert B; Kisiela M; Wsol V; Martin HJ; Maser E
Chem Biol Interact; 2011 May; 191(1-3):95-103. PubMed ID: 21256830
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of 8-hydroxy-2-iminochromene derivatives as selective and potent inhibitors of human carbonyl reductase 1.
Hu D; Miyagi N; Arai Y; Oguri H; Miura T; Nishinaka T; Terada T; Gouda H; El-Kabbani O; Xia S; Toyooka N; Hara A; Matsunaga T; Ikari A; Endo S
Org Biomol Chem; 2015 Jul; 13(27):7487-99. PubMed ID: 26068795
[TBL] [Abstract][Full Text] [Related]
14. Study on the interaction between 3 flavonoid compounds and alpha-amylase by fluorescence spectroscopy and enzymatic kinetics.
Li Y; Gao F; Gao F; Shan F; Bian J; Zhao C
J Food Sci; 2009 Apr; 74(3):C199-203. PubMed ID: 19397703
[TBL] [Abstract][Full Text] [Related]
15. Structural evidence for the inhibition of grape dihydroflavonol 4-reductase by flavonols.
Trabelsi N; Petit P; Manigand C; Langlois d'Estaintot B; Granier T; Chaudière J; Gallois B
Acta Crystallogr D Biol Crystallogr; 2008 Aug; D64(Pt 8):883-91. PubMed ID: 18645237
[TBL] [Abstract][Full Text] [Related]
16. Interactions between flavonoids and hemoglobin in lecithin liposomes.
Xi J; Guo R
Int J Biol Macromol; 2007 Mar; 40(4):305-11. PubMed ID: 16997370
[TBL] [Abstract][Full Text] [Related]
17. The antibacterial efficacy of an aceraceous plant [Shantung maple (Acer truncatum Bunge)] may be related to inhibition of bacterial beta-oxoacyl-acyl carrier protein reductase (FabG).
Zhang F; Luo SY; Ye YB; Zhao WH; Sun XG; Wang ZQ; Li R; Sun YH; Tian WX; Zhang YX
Biotechnol Appl Biochem; 2008 Oct; 51(Pt 2):73-8. PubMed ID: 18208374
[TBL] [Abstract][Full Text] [Related]
18. Molecular simulations bring new insights into flavonoid/quercetinase interaction modes.
Fiorucci S; Golebiowski J; Cabrol-Bass D; Antonczak S
Proteins; 2007 Jun; 67(4):961-70. PubMed ID: 17373707
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of mammalian thioredoxin reductase by black tea and its constituents: implications for anticancer actions.
Du Y; Wu Y; Cao X; Cui W; Zhang H; Tian W; Ji M; Holmgren A; Zhong L
Biochimie; 2009 Mar; 91(3):434-44. PubMed ID: 19059456
[TBL] [Abstract][Full Text] [Related]
20. Human carbonyl reductase 1 participating in intestinal first-pass drug metabolism is inhibited by fatty acids and acyl-CoAs.
Hara A; Endo S; Matsunaga T; El-Kabbani O; Miura T; Nishinaka T; Terada T
Biochem Pharmacol; 2017 Aug; 138():185-192. PubMed ID: 28450226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
